Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis

Mol Immunol. 2013 Dec;56(4):540-8. doi: 10.1016/j.molimm.2013.05.231. Epub 2013 Aug 1.

Abstract

The complex interplay between cytokines and chemokines regulates innate and adaptive immune responses against pathogens; specifically, cytokine and chemokine expression drives activation of immune effector cells and their recruitment to tissue infection sites. Herein, we inoculated dogs with Leishmania braziliensis antigens plus saponin (the LBSap vaccine), as well as with the vaccine components, and then used real-time PCR to evaluate the kinetics of dermal expression of mRNAs of cytokines (IL-12, IFN-γ, TNF-α, IL-4, IL-13, TGF-β and IL-10) and chemokines (CCL2, CCL4, CCL5, CCL21 and CXCL8) 1, 12, 24 and 48 h after inoculation. We also evaluated the correlation between cytokine and chemokine expression and dermal cellularity. The LBSap vaccine induced high levels of IL-12 and IL-10 expression at 12 and 24 h, respectively. Furthermore, we observed positive correlations between IL-12 and IL-13 expression, IFN-γ and IL-13 expression, and IL-13 and TGF-β expression, suggesting that a mixed cytokine microenvironment developed after immunization with the vaccine. Inoculation with the saponin adjuvant alone induced a chemokine and cytokine expression profile similar to that observed in the LBSap group. CCL4 and CXCL8 chemokine expression was up regulated by the LBSap vaccine. CCL5 expression was initially highest in the LBSap group, but at 48 h, expression was highest in the LB group. Information about the kinetics of the immune response to this vaccine gained using this dog model will help to elucidate the mechanisms of and factors involved in a protective response against Leishmania infection and will aid in establishing rational approaches for the development of vaccines against canine visceral leishmaniasis.

Keywords: Adjuvants; Canine visceral leishmaniasis; Chemokines; Cytokines; Real-time PCR; Saponin; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chemokine CCL4 / genetics
  • Chemokine CCL4 / immunology
  • Chemokine CCL5 / genetics
  • Chemokine CCL5 / immunology
  • Chemokines / genetics
  • Chemokines / immunology*
  • Cytokines / genetics
  • Cytokines / immunology*
  • Dermis / immunology*
  • Dermis / metabolism
  • Dermis / parasitology
  • Dog Diseases / immunology
  • Dog Diseases / parasitology
  • Dog Diseases / prevention & control
  • Dogs
  • Female
  • Gene Expression / immunology
  • Host-Pathogen Interactions / immunology
  • Immunization
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Interleukin-12 / genetics
  • Interleukin-12 / immunology
  • Interleukin-8 / genetics
  • Interleukin-8 / immunology
  • Leishmania braziliensis / immunology
  • Leishmania braziliensis / physiology
  • Leishmaniasis Vaccines / administration & dosage
  • Leishmaniasis Vaccines / immunology*
  • Leishmaniasis, Visceral / genetics
  • Leishmaniasis, Visceral / immunology
  • Leishmaniasis, Visceral / veterinary
  • Male
  • Reverse Transcriptase Polymerase Chain Reaction
  • Saponins / administration & dosage
  • Saponins / immunology
  • Time Factors

Substances

  • Chemokine CCL4
  • Chemokine CCL5
  • Chemokines
  • Cytokines
  • Interleukin-8
  • Leishmaniasis Vaccines
  • Saponins
  • Interleukin-10
  • Interleukin-12